Avancer Group Inc. Information

Avancer advises boards, CEOs, and investors in healthcare, life sciences, MedTech, and digital health on AI governance, AI strategy, and responsible AI. We help leaders turn AI investment and strategic transformation into measurable business value, with clear accountability for decisions and execution. Leaders engage Avancer to: • Realize value: prioritize AI investments and adoption, define success measures, and connect transformation to productivity, cost, growth, and decision quality. • Strengthen oversight: align board and executive responsibilities, AI governance, enterprise risk, and implementation. • Allocate capital: assess strategic fit, conduct due diligence, and guide M&A, commercialization, integration, turnarounds, and portfolio decisions. • Build trust and resilience: integrate responsible AI, data governance, and AI risk management into oversight and execution. Founded in 2001, Avancer provides strategic advisory, board and CEO advisory, executive coaching, and interim executive leadership. We translate clinical, technical, regulatory, and financial complexity into clear choices and practical execution plans. Founder & Principal Jeffrey DiFrancesco brings four decades of experience across corporate boards, executive leadership, and advisory roles. His career results include scaling healthcare platforms serving 94 million patients, 19,000 clinical sites, and 65,000 providers; leading transformations that cut cycle time by more than 35% and delivered more than 15% cost-efficiency gains within 18 months; and enabling a multinational joint venture to achieve post-merger targets within six months. Our experience spans Software as a Medical Device, real-world data and evidence, biosimulation, clinical trial innovation, and environments shaped by FDA, EMA, HIPAA, GDPR, quality systems, cybersecurity, and interoperability requirements. Discuss your priorities: avancer.co/book.